Kwang Dong Pharmaceutical Co., Ltd. (009290) Stock Statistics & Valuation Metrics

Kwang Dong Pharmaceutical Co., Ltd. has a market cap or net worth of KRW 310.46B. The enterprise value is KRW 473.63B.

Market Cap

KRW 310.46B

Enterprise Value

KRW 473.63B

Kwang Dong Pharmaceutical Co., Ltd. has 49,799,810 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

49,799,810

Owned by Insiders

―

Owned by Institutions

14.50%

Kwang Dong Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.07%.

Return on Equity (ROE)

0.03

Return on Assets (ROA)

0.02

Return on Invested Capital (ROIC)

2.07%

Return on Capital Employed (ROCE)

0.04

Revenue Per Employee

1.62B

Profits Per Employee

20.52M

Employee Count

1,022

Asset Turnover

1.26

Inventory Turnover

6.71

The current PE Ratio of Kwang Dong Pharmaceutical Co., Ltd. is 13.18. Kwang Dong Pharmaceutical Co., Ltd.’s PEG ratio is -0.51.

PE Ratio

13.18

PS Ratio

0.19

PB Ratio

0.61

Price to FCF

76.19

Price to Operating Cash Flow

21.91

PEG Ratio

-0.51

In the last 12 months, Kwang Dong Pharmaceutical Co., Ltd. had revenue of 1.66T and earned 20.97B in profits. Earnings per share was 521.00.

Revenue

1.66T

Gross Profit

293.22B

Operating Income

31.05B

Pretax Income

30.98B

Net Income

20.97B

EBITDA

48.54B

Earnings Per Share (EPS)

521.00

In the last 12 months, operating cash flow was 17.69B and capital expenditures -13.34B, giving a free cash flow of 4.34B billion.

Operating Cash Flow

17.69B

Free Cash Flow

4.34B

Free Cash Flow per Share

74.67

Kwang Dong Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 1.52%

Dividend Per Share

―

Dividend Yield

1.52%

Payout Ratio

N/A

Free Cash Flow Yield

1.32%

Earnings Yield

5.68%

Beta

0.16

52-Week Price Change

14.19%

50-Day Moving Average

6476.00

200-Day Moving Average

7015.66

Relative Strength Index (RSI)

55.66

Average Volume (3m)

143.51K

Kwang Dong Pharmaceutical Co., Ltd. upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 12, 2026

Next Earnings Date

Nov 11, 2026

Ex-Dividend Date

―

Kwang Dong Pharmaceutical Co., Ltd. as a current ratio of 1.36, with Debt / Equity ratio of 46.25%

Current Ratio

1.36

Quick Ratio

0.98

Debt to Market Cap

0.93

Net Debt to EBITDA

3.34

Interest Coverage Ratio

2.82

In the past 12 months, Kwang Dong Pharmaceutical Co., Ltd. has paid 9.65B in taxes.

Income Tax

9.65B

Effective Tax Rate

0.31

Kwang Dong Pharmaceutical Co., Ltd. EV to EBITDA ratio is -38.12, with an EV/FCF ratio of 124.65.

EV to Sales

0.32

EV to EBITDA

-38.12

EV to Free Cash Flow

124.65

EV to Operating Cash Flow

30.62

Kwang Dong Pharmaceutical Co., Ltd. has KRW 177.70B in cash and marketable securities with KRW 300.93B in debt, giving a net cash position of -KRW 123.23B billion.

Cash & Marketable Securities

KRW 177.70B

Total Debt

KRW 300.93B

Net Cash

-KRW 123.23B

Net Cash Per Share

-KRW 2,474.41

Tangible Book Value Per Share

KRW 11.18K

Gross margin is 17.61%, with operating margin of 1.96%, and net profit margin of 1.28%.

Gross Margin

17.61%

Operating Margin

1.96%

Pretax Margin

1.93%

Net Profit Margin

1.28%

EBITDA Margin

-0.83%

EBIT Margin

-2.02%

The average price target for Kwang Dong Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

5.50%

EPS Growth Forecast

-26.11%

Smart Score

―

AI Score

52